Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment
暂无分享,去创建一个
[1] Wei Huang,et al. KCNQ1 Gain-of-Function Mutation in Familial Atrial Fibrillation , 2003, Science.
[2] Ying Wang,et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. , 2003, Science.
[3] C. Lau,et al. Defibrillation-guided radiofrequency ablation of atrial fibrillation secondary to an atrial focus. , 1999, Journal of the American College of Cardiology.
[4] N. Kerin,et al. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation. , 1996, Archives of internal medicine.
[5] R. Falk. Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin. , 1990, British heart journal.
[6] M. Allessie,et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.
[7] L. Køber,et al. Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function: A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy , 2001, Circulation.
[8] Allessie,et al. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. , 1977, Circulation research.
[9] Frank J. Hildner,et al. ArticlesAntithrombotic Therapy in Atrial Fibrillation , 1989 .
[10] Hendrik Bonnemeier,et al. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. , 2003, Circulation.
[11] S Nattel,et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. , 2000, The New England journal of medicine.
[12] A L Waldo,et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.
[13] S. Hohnloser,et al. Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial , 2000, The Lancet.
[14] J Haaksma,et al. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? , 1998, Journal of the American College of Cardiology.
[15] G. Lip,et al. Antithrombotic therapy for atrial fibrillation , 2002, BMJ : British Medical Journal.
[16] M. Allessie,et al. Circus Movement in Rabbit Atrial Muscle as a Mechanism of Tachycardia , 1973, Circulation research.
[17] Amiodarone to Prevent Recurrence of Atrial Fibrillation , 2000 .
[18] A. Kadish,et al. Endocardial mapping of atrial fibrillation in the human right atrium using a non-contact catheter. , 2000, European heart journal.
[19] V. Fuster,et al. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference , 2001, Circulation.
[20] 李永军,et al. Atrial Fibrillation , 1999 .
[21] J Clémenty,et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.
[22] Crijns,et al. Functional capacity before and after cardioversion of atrial fibrillation: a controlled study. , 1994, British heart journal.
[23] C. Pandozi,et al. Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation. , 1998, Circulation.
[24] H. Wellens,et al. Are electrophysiological changes induced by longer lasting atrial fibrillation reversible? :observations using the atrial defibrillator. , 1999, Circulation.